Brainstorm Cell Theraputc (BCLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -23,253 | -13,948 | -4,952 | -4,982 | -8,488 |
| Depreciation Amortization | 164 | 110 | 85 | 712 | 922 |
| Accounts receivable | 690 | -238 | -2,792 | 379 | 204 |
| Other Working Capital | 11,053 | 431 | 1,887 | -1,709 | 43 |
| Other Operating Activity | 99 | 1,257 | 3,408 | -258 | -89 |
| Operating Cash Flow | $-11,247 | $-12,388 | $-2,364 | $-5,858 | $-7,408 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 6,089 | -849 | 4,170 | 6,084 | -11,237 |
| PPE Investments | -473 | -369 | -180 | -103 | -45 |
| Purchase Of Investment | N/A | N/A | -4 | -4 | -1 |
| Investing Cash Flow | $5,616 | $-1,218 | $3,986 | $5,977 | $-11,283 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,064 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 3,161 | 12,065 | 314 | N/A | 14,868 |
| Financing Cash Flow | $5,225 | $12,065 | $314 | $N/A | $14,868 |
| Beginning Cash Position | 942 | 2,483 | 547 | 428 | 4,251 |
| End Cash Position | 536 | 942 | 2,483 | 547 | 428 |
| Net Cash Flow | $-406 | $-1,541 | $1,936 | $119 | $-3,823 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,247 | -12,388 | -2,364 | -5,858 | -7,408 |
| Capital Expenditure | -473 | -369 | -180 | -103 | -45 |
| Free Cash Flow | -11,720 | -12,757 | -2,544 | -5,961 | -7,453 |